Skip to main content
Caplight Logo









JNPMEDI

JNPMEDI

Private
IncheonHealthcare & Life Scienceshttps://www.jnpmedi.com/

Last Round

Grant

Jan 8, 2026

Est. Valuation

$37M

Total Funding Raised

$13.67M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

JNPMEDI is a healthcare technology company that provides a cloud-based, AI-powered medical data platform for clinical research and trial operations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

decentralized clinical trialDCTclinical trial managementelectronic data captureEDCeCOAeConsenteClinicalclinical trial softwareRTSMclinical trial automationvertical SaaSmedical coding AISDTM conversionremote patient monitoringclinical research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

JNPMEDI Comparables

Compare JNPMEDI with similar companies based on industry and business-model similarity.

JNPMEDI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CRScube
85%
ObvioHealth
80%
Curebase
80%

JNPMEDI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 8, 2026
Corporate FundingAug 13, 2025
Series ANov 22, 2022
SeedJan 18, 2022
SeedDec 8, 2021

Key People

Founding team and executive leadership

Jonghyun Park

CEO Staff

Executive Team

Kwunho Jeong

Chief Executive Officer

Executive Team

Minjung Jade Kim

CEO Staff, Product Portfolio Manager

Executive Team

Youngyong Park

Chief Technology Officer

Executive Team

JNPMEDI Investors

Notable investors and investment history

JNPMEDI investors
InvestorRounds
Kakao VenturesSeed, Series A
TBT PartnersCorporate Funding
Murex PartnersSeed, Series A
Pavilion CapitalSeries A
Gentium PartnersSeed, Series A
Government of South KoreaGrant
AJU IB InvestmentSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 37% MoM.

  • Jan 8, 2026

    Received funding from the Government of South Korea.

JNPMEDI Filings

Explore SEC and related filing metadata, where available.

JNPMEDI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about JNPMEDI's valuation, stock price, and market status.

Is JNPMEDI a public or private company?

JNPMEDI is a private company.

What is the current stock price of JNPMEDI?

JNPMEDI is a private company with no public stock price. No recent secondary market data is available.

How much is JNPMEDI worth (valuation)?

Valuation information for JNPMEDI is not publicly available.

Can I buy JNPMEDI stock?

JNPMEDI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was JNPMEDI's last funding round?

JNPMEDI's most recent funding round was Series A on November 22, 2022.

Who are the main investors in JNPMEDI?

Key investors in JNPMEDI include Pavilion Capital.

Will JNPMEDI IPO soon?

No public IPO plans have been announced for JNPMEDI.

How can I track JNPMEDI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor JNPMEDI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIncheon
Employee Range71
Year Founded2020
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?